Cargando…

Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates

SARS-CoV-2 emerged in December 2019 and quickly spread worldwide, continuously striking with an unpredictable evolution. Despite the success in vaccine production and mass vaccination programs, the situation is not still completely controlled, and therefore accessible second-generation vaccines are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prenafeta, Antoni, Bech-Sàbat, Gregori, Moros, Alexandra, Barreiro, Antonio, Fernández, Alex, Cañete, Manuel, Roca, Mercè, González-González, Luis, Garriga, Carme, Confais, Joachim, Toussenot, Marion, Contamin, Hugues, Pizzorno, Andrés, Rosa-Calatrava, Manuel, Pradenas, Edwards, Marfil, Silvia, Blanco, Julià, Rica, Paula Cebollada, Sisteré-Oró, Marta, Meyerhans, Andreas, Lorca, Cristina, Segalés, Joaquim, Prat, Teresa, March, Ricard, Ferrer, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299950/ https://www.ncbi.nlm.nih.gov/pubmed/37502366 http://dx.doi.org/10.1016/j.isci.2023.107224

Ejemplares similares

Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
por: Barreiro, Antonio, et al.
Publicado: (2023)

Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial
por: Corominas, Júlia, et al.
Publicado: (2023)

IR-7883. Inmunogenicidad de una vacuna de proteína recombinante contra el SARS-CoV-2 (PHH-1V) como primovacunación en adultos sanos en Vietnam
por: Fumaña, C. Borralleras, et al.
Publicado: (2022)

First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain
por: Fernández-Bastit, Leira, et al.
Publicado: (2021)

The PHH-1V HIPRA vaccine: a new tool in the vaccination strategy against COVID-19
por: Borralleras, Cristina, et al.
Publicado: (2023)

PHH3 as an Ancillary Mitotic Marker in Gastrointestinal Stromal Tumors
por: Shin, Yooju, et al.
Publicado: (2015)

Anti-SARS-COV-2 specific immunity in HIV immunological non-responders after mRNA-based COVID-19 vaccination
por: Sisteré-Oró, Marta, et al.
Publicado: (2022)

Functional cure of a chronic virus infection by shifting the virus - host equilibrium state
por: Bocharov, Gennady, et al.
Publicado: (2022)

Pooling analysis on prognostic value of PHH3 expression in cancer patients
por: Hao, Qian, et al.
Publicado: (2018)

IR-7885. Seguridad de una vacuna de proteína recombinante basada en un heterodímero de fusión del dominio de unión al receptor del SARS-CoV-2 (PHH-1V) como primovacunación en adultos sanos en Vietnam
por: de Cambra Florensa, S., et al.
Publicado: (2022)

Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy
por: Pizzorno, Andrés, et al.
Publicado: (2019)

In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2
por: Pizzorno, Andrés, et al.
Publicado: (2020)

Utility of PHH3 in Evaluation of Mitotic Index in Breast Carcinoma and Impact on Tumor Grade
por: Mirzaiian, Elham, et al.
Publicado: (2020)

pHH3 and survivin are co-expressed in high-risk endometrial cancer and are prognostic relevant
por: Brunner, A, et al.
Publicado: (2012)

Treatments for COVID-19: Lessons from 2020 and new therapeutic options
por: Salasc, Fanny, et al.
Publicado: (2022)

Brief Research Report: Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 Vaccination
por: Sisteré-Oró, Marta, et al.
Publicado: (2022)

THU105 PHH Parameters Are New Minimal-Invasive Markers Of Glycemic Homeostasis Of Type 1 Diabetes
por: Harvengt, Antoine
Publicado: (2023)

Identification and Characterization of Swine Influenza Virus H1N1 Variants Generated in Vaccinated and Nonvaccinated, Challenged Pigs
por: López-Valiñas, Álvaro, et al.
Publicado: (2021)

Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load
por: Gonçalves, Antonio, et al.
Publicado: (2020)

Phosphohistone H3 (pHH3) is a prognostic and epithelial to mesenchymal transition marker in diffuse gliomas
por: Zhu, Ping, et al.
Publicado: (2016)

The prognostic importance of PD-L1, PTEN, PHH3, and KI-67 expressions in invasive breast carcinoma
por: Imamoglu, Eda Hilal, et al.
Publicado: (2022)

Flagellin From Pseudomonas aeruginosa Modulates SARS-CoV-2 Infectivity in Cystic Fibrosis Airway Epithelial Cells by Increasing TMPRSS2 Expression
por: Ruffin, Manon, et al.
Publicado: (2021)

Transcriptional Profiling of Immune and Inflammatory Responses in the Context of SARS-CoV-2 Fungal Superinfection in a Human Airway Epithelial Model
por: Nicolas de Lamballerie, Claire, et al.
Publicado: (2020)

IE-7884. Inmunogenicidad de una vacuna de proteína recombinante contra el SARS-CoV-2 (PHH-1V) como refuerzo heterólogo en individuos previamente vacunados contra la COVID-19
por: de Cambra Florensa, S., et al.
Publicado: (2022)

Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus
por: Terrier, Olivier, et al.
Publicado: (2021)

In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses
por: Checkmahomed, Liva, et al.
Publicado: (2020)

Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro
por: Jonsdottir, Hulda R., et al.
Publicado: (2022)

410: Pseudomonas aeruginosa modulates SARS-CoV-2 infectivity in CF airway epithelial cells by increasing expression of the host protease TMPRSS2
por: Ruffin, M., et al.
Publicado: (2021)

tyrB-2 and phhC genes of Pseudomonas putida encode aromatic amino acid aminotransferase isozymes: evidence at the protein level
por: Szkop, Michał, et al.
Publicado: (2013)

A retrospective study on expression and clinical significance of PHH3, Ki67 and P53 in bladder exophytic papillary urothelial neoplasms
por: Qi, Gaoxiu, et al.
Publicado: (2023)

Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals
por: Trinité, Benjamin, et al.
Publicado: (2021)

Rapid SARS-CoV-2 Inactivation in a Simulated Hospital Room Using a Mobile and Autonomous Robot Emitting Ultraviolet-C Light
por: Lorca-Oró, Cristina, et al.
Publicado: (2021)

Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia
por: Pizzorno, Andrés, et al.
Publicado: (2020)

Agreement and differential use of laboratory methods for the detection and quantification of SARS-CoV-2 in experimentally infected animals
por: Usai, Carla, et al.
Publicado: (2022)

Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection
por: Pradenas, Edwards, et al.
Publicado: (2022)

Protective effect of a polyvalent influenza DNA vaccine in pigs
por: Karlsson, Ingrid, et al.
Publicado: (2018)

DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs
por: Sisteré-Oró, Marta, et al.
Publicado: (2019)

Influenza NG-34 T cell conserved epitope adjuvanted with CAF01 as a possible influenza vaccine candidate
por: Sisteré-Oró, Marta, et al.
Publicado: (2020)

Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS‐CoV‐2 mRNA‐1237 vaccine in patients with solid tumors
por: Felip, Eudald, et al.
Publicado: (2022)

Conserved HA-peptide NG34 formulated in pCMV-CTLA4-Ig reduces viral shedding in pigs after a heterosubtypic influenza virus SwH3N2 challenge
por: Sisteré-Oró, Marta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_aijk4c6eci25b7libdlevkmogj